AR049350A1 - Benzimidazoles triciclicos substituidos - Google Patents
Benzimidazoles triciclicos substituidosInfo
- Publication number
- AR049350A1 AR049350A1 ARP050102338A ARP050102338A AR049350A1 AR 049350 A1 AR049350 A1 AR 049350A1 AR P050102338 A ARP050102338 A AR P050102338A AR P050102338 A ARP050102338 A AR P050102338A AR 049350 A1 AR049350 A1 AR 049350A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- fluoro
- hydroxy
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Abstract
Los compuestos inhiben la secrecion gástrica y tienen propiedades de proteccion gástrica e intestinal excelentes. Reivindicacion 1: Un compuesto de benzimidazol tricíclico substituído, caracterizado por la formula (1), donde R1 es H, halogeno, alquilo C1-4, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-4, alcoxi C1-4, alcoxi C1-4-alquilo C1-4, alcoxi C1-4-carbonilo, alquenilo C2-4, alquinilo C2-4, fluoro-alquilo C1-4, fluoro-alcoxi C1-4-alquilo C1-4 o hidroxi-alquilo C1-4; R2 es H, alquilo C1-4, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-4, alcoxi C1-4-alquilo C1-4, alquenilo C2-4, alquinilo C2-4, fluoro-alquilo C1-4 o hidroxi-alquilo C1-4; R3 es halogeno, fluoro-alquilo C1-4, carboxilo, -CO-alcoxi C1-4, hidroxi-alquilo C1- 4, alcoxi C1-4-alquilo C1-4, alcoxi C1-4-alcoxi C1-4-alquilo C1-4, fluoro-alcoxi C1-4-alquilo C1-4, ciano, el grupo -CO-NR31R32, el grupo SO2-NR31R32 o el grupo Het, donde R31 es H, hidroxilo, alquilo C1-7, hidroxi-alquilo C1-4, alcoxi C1-4-alquilo C1-4, cicloalquilo C3-7 o amino y R32 es H, alquilo C1-7, hidroxi-alquilo C1-4 o alcoxi C1-4-alquilo C1-4, o donde R31 y R32 conjuntamente, incluyendo el átomo de N al cual ambos están ligados, son un grupo pirrolidino, piperidino, piperazino, N- alquil C1-4-piperazino, morfolino, aziridino o azetidino y Het es un residuo heterocíclico, sustituido por R33, R34 y R35, seleccionado del grupo formado por oxadiazol, dihidrooxazol, dihidroimidazol, oxazol, imidazol, isoxazol, dihidroisoxazol, pirazol y tetrazol, donde R33 es H, alquilo C1-4, hidroxi-alquilo C1-4, alcoxi C1-4, alqueniloxi C2-4, alquil C1-4-carbonilo, carboxi, alcoxi C1-4-carbonilo, carboxi-alquilo C1-4, alcoxi C1-4-carbonil-alquilo C1-4, halogeno, hidroxi, arilo, aril- alquilo C1-4, ariloxi, aril-alcoxi C1-4, trifluorometilo, nitro, amino, mono- o di-alquilamino C1-4, alquil C1-4-carbonilamino, alcoxi C1-4-carbonilamino, alcoxi C1-4-alcoxi C1-4-carbonilamino o sulfonilo; R34 es H, alquilo C1-4, alcoxi C1-4, alcoxi C1-4-carbonilo, halogeno, trifluorometilo o hidroxi; R35 es H, alquilo C1-4, alcoxi C1-4, alcoxi C1-4-carbonilo, halogeno, trifluorometilo o hidroxi; R4 es H, halogeno, alquilo C1-4, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-4, alcoxi C1-4- alquilo C1-4, fluoro-alquilo C1-4, fluoro-alcoxi C1-4-alquilo C1-4, hidroxi-alquilo C1-4, hidroxi, alcoxi C1-4, cicloalcoxi C3-7, cicloalquil C3-7-alcoxi C1-4, alcoxi C1-4-alcoxi C1-4, fluoro-alcoxi C1-4, fluoro-alcoxi C1-4-alcoxi C1-4, hidorxi- alcoxi C1-4, alqueniloxi C2-4 o alquiniloxi C2-4; R5 es H, alquilo C1-4, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-4, alcoxi C1-4-alquilo C1-4, fluoro-alquilo C1-4, fluoro-alcoxi C1-4-alquilo C1-4 o hidroxi-alquilo C1-4; R6 es H, halogeno, alquilo C1-4 o fluoro-alquilo C1-4; R7 es H, halogeno, alquilo C1-4 o fluoro-alquilo C1-4, y donde arilo es fenilo o fenilo sustituido por 1, 2 o 3 sustituyentes iguales o diferentes del grupo formado por alquilo C1-4, alcoxi C1-4, carboxi, alcoxi C1-4-carbonilo, halogeno, trifluorometilo, nitro, trifluorometoxi, hidroxi y ciano, y sus sales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04102628 | 2004-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049350A1 true AR049350A1 (es) | 2006-07-19 |
Family
ID=34929186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102338A AR049350A1 (es) | 2004-06-09 | 2005-06-08 | Benzimidazoles triciclicos substituidos |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070244154A1 (es) |
EP (1) | EP1758900B1 (es) |
JP (1) | JP2008501766A (es) |
AR (1) | AR049350A1 (es) |
AT (1) | ATE374774T1 (es) |
AU (1) | AU2005251943A1 (es) |
CA (1) | CA2568856A1 (es) |
DE (1) | DE602005002751T2 (es) |
TW (1) | TW200611903A (es) |
WO (1) | WO2005121139A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105919998B (zh) | 2009-07-09 | 2021-08-24 | 拉夸里亚创药株式会社 | 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂 |
WO2016126726A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors |
ES2903523T3 (es) | 2015-02-02 | 2022-04-04 | Valo Health Inc | Acidos 3-aril-4-amido-biciclico [4.5.0]hidroxámicos como inhibidores de HDAC |
EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8604566D0 (sv) * | 1986-10-27 | 1986-10-27 | Haessle Ab | Novel compunds |
SE9602286D0 (sv) * | 1996-06-10 | 1996-06-10 | Astra Ab | New compounds |
DE69938192D1 (en) * | 1998-11-03 | 2008-04-03 | Nycomed Gmbh | Imidazonaphthyridine |
MXPA04001277A (es) * | 2001-08-10 | 2004-05-27 | Altana Pharma Ag | Imidazopiridinas triciclicas. |
EA200501537A1 (ru) * | 2003-04-04 | 2006-06-30 | Алтана Фарма Аг | Циклические бензимидазолы |
-
2005
- 2005-06-07 WO PCT/EP2005/052590 patent/WO2005121139A1/en active IP Right Grant
- 2005-06-07 AT AT05752619T patent/ATE374774T1/de not_active IP Right Cessation
- 2005-06-07 CA CA002568856A patent/CA2568856A1/en not_active Abandoned
- 2005-06-07 DE DE602005002751T patent/DE602005002751T2/de not_active Expired - Fee Related
- 2005-06-07 JP JP2007526419A patent/JP2008501766A/ja active Pending
- 2005-06-07 US US11/628,041 patent/US20070244154A1/en not_active Abandoned
- 2005-06-07 AU AU2005251943A patent/AU2005251943A1/en not_active Abandoned
- 2005-06-07 EP EP05752619A patent/EP1758900B1/en active Active
- 2005-06-08 AR ARP050102338A patent/AR049350A1/es unknown
- 2005-06-09 TW TW094119091A patent/TW200611903A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ATE374774T1 (de) | 2007-10-15 |
US20070244154A1 (en) | 2007-10-18 |
WO2005121139A8 (en) | 2006-11-23 |
DE602005002751T2 (de) | 2008-07-17 |
EP1758900B1 (en) | 2007-10-03 |
EP1758900A1 (en) | 2007-03-07 |
CA2568856A1 (en) | 2005-12-22 |
JP2008501766A (ja) | 2008-01-24 |
WO2005121139A1 (en) | 2005-12-22 |
AU2005251943A1 (en) | 2005-12-22 |
DE602005002751D1 (de) | 2007-11-15 |
TW200611903A (en) | 2006-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20141827A1 (es) | Inhibidores de proteinas quinasas | |
AR084588A1 (es) | Compuesto heterociclico fusionado y su uso para el control de plagas | |
AR043063A1 (es) | Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas | |
PE20061038A1 (es) | Derivados del 1,5-difenil-1h-pirazol-3-il) oxadiazol como agentes antagonistas cb1 y su preparacion | |
ES2422299T3 (es) | Indoles (4,5-dihidro) indoles tricíclicos | |
PE20051141A1 (es) | Inhibidores de la polimerasa viral | |
CO6220911A2 (es) | Composicion herbicida que comprende derivados de isoxazolinma como ingredientes activos | |
PE20091952A1 (es) | Compuestos de tiazole y oxazole de sulfonamida de benzeno | |
PE20091492A1 (es) | Compuestos y composiciones como inhibidores de c-kit y de la cinasa pdgfr | |
AR047538A1 (es) | Piridazinonas como antagonistas de las integrinas alfa4 | |
PE20131377A1 (es) | Triazina-oxadiazoles | |
PE20080895A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
PE20110924A1 (es) | Derivados de 2, 4-diamino-pirimidina n2, n4-disustituidos como inhibidores de jak3 | |
PE20200608A1 (es) | Nuevos derivados de azaquinolina | |
PE20130158A1 (es) | Inhibidores no nucleosidicos de la transcriptasa inversa | |
PE20090709A1 (es) | Compuestos heterociclico de 5 miembros | |
PE20130155A1 (es) | Derivados de ariletinilo | |
ES2564782T3 (es) | Compuestos derivados de 1-aril-5-alquil pirazol, procedimientos de fabricación y procedimientos de utilización de los mismos | |
PE20091371A1 (es) | Inhibidores de hsp90 | |
AR060605A1 (es) | Derivados de diazepano como antagonistas del receptor ccr2 | |
CO6321244A2 (es) | Pirrolopiridinas como inhibidores de cinasa | |
PE20090366A1 (es) | Composicion de efecto herbicida | |
PE20110028A1 (es) | Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato | |
AR072787A1 (es) | Compuestos y composiciones como inhibidores de cinasa | |
ES2567311T3 (es) | 6-(3-Aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinas como antagonistas del receptor de ADP |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |